Tous Actualités
Suivre
Abonner Gerresheimer AG

Gerresheimer AG

Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share

Duesseldorf, Germany (ots/PRNewswire)

Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG.

"In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and dynamic. We are investing and working to grow our innovation pipeline. These efforts continue undiminished and we have not been distracted by the Covid-19 pandemic. As a key supplier to the pharma and healthcare industry, we have significant responsibility for ensuring patients receive the medication they need and thus in maintaining our customers' delivery capacity. We have guaranteed this over the past few months and maintained our own delivery capacity at all times. At present, we are seeing new opportunities arise in the pharma business. What is very high demand for injection vials for future Covid-19 vaccination campaigns is currently providing tailwind. Our clear-cut goal is to set our Gerresheimer on the path to sustainable, profitable growth," said Dietmar Siemssen, CEO of Gerresheimer AG, at the Annual General Meeting.

The dividend has been raised by 4% to EUR 1.20 per dividend-entitled share, compared with a dividend of EUR 1.15 per share distributed in the prior year. The dividend will be paid out on June 29, 2020.

A large majority voted in favor of the resolution formally ratifying the actions of the Management Board and Supervisory Board in the financial year 2019. Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Duesseldorf, was elected as auditor for the financial year 2020. A resolution was also passed to amend the Articles of Association to include provisions on the proof of share ownership to be submitted by a shareholder when registering for the Annual General Meeting. This amendment was made necessary by changes to the German Stock Corporation Act.

At today's Annual General Meeting, 86.03% of the capital stock was represented. The detailed voting results on all items of the Annual General Meeting agenda are available here: 
 http://www.gerresheimer.com/en/investor-relations/annual-general-meeting

The speech delivered by the CEO at the Annual General Meeting is available here: http://www.gerresheimer.com/en/investor-relations/annual-general-meeting

The Annual Report is available here:

www.gerresheimer.com/en/investor-relations/reports

www.gerresheimer.com

Contact: 
Jens Kürten
Group Senior Director Communication & Marketing
+49 211 6181-250 
jens.kuerten@gerresheimer.com

Plus de actualités: Gerresheimer AG
Plus de actualités: Gerresheimer AG
  • 19.11.2019 – 13:38

    New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical

    Dusseldorf, Germany (ots/PRNewswire) - - SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment - Sanofi terminates development project for micro pumps for patients with diabetes - Further projects with pharma customers for various therapy areas for the micro pump started Sensile Medical, a subsidiary of Gerresheimer AG, has signed ...

  • 11.07.2019 – 08:10

    Gerresheimer Reports Strong Second Quarter

    - Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price compo­nents in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at constant exchange rates for the financial year 2019 approximately EUR 295m (plus ...

  • 14.05.2019 – 10:31

    Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

    Duesseldorf, Germany (ots/PRNewswire) - Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management ...